These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18095229)

  • 1. Optimizing antipseudomonal therapy in critical care.
    Iredell JR
    Semin Respir Crit Care Med; 2007 Dec; 28(6):656-61. PubMed ID: 18095229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipyocyanic antibiotic therapy. Principles and efficacy factors].
    Cohen R
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S10-2. PubMed ID: 17370390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.
    Ho SA; Lee TW; Denton M; Conway SP; Brownlee KG
    J Cyst Fibros; 2009 Jan; 8(1):43-6. PubMed ID: 18829398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Foreign body infections--biofilms and quorum sensing].
    Høiby N; Johansen HK; Ciofu O; Jensen PØ; Bjarnsholt T; Givskov M
    Ugeskr Laeger; 2007 Nov; 169(48):4163-6. PubMed ID: 18211783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.
    Tsukayama DT; van Loon HJ; Cartwright C; Chmielewski B; Fluit AC; van der Werken C; Verhoef J;
    Int J Antimicrob Agents; 2004 Oct; 24(4):339-45. PubMed ID: 15380258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current therapies for pseudomonas aeruginosa.
    Giamarellou H; Kanellakopoulou K
    Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
    Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
    Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
    Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N
    Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we be afraid of the Green Monster?
    Rumbaugh K
    Crit Care Med; 2009 May; 37(5):1826-7. PubMed ID: 19373066
    [No Abstract]   [Full Text] [Related]  

  • 10. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure.
    Hayes D; Kanga JF; Anstead MI; Kuhn RJ
    Pediatr Pulmonol; 2008 May; 43(5):511-3. PubMed ID: 18383117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis infections: treatment strategies and prospects.
    George AM; Jones PM; Middleton PG
    FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Pseudomonas aeruginosa infection in critically ill patients.
    Grossi P; Dalla Gasperina D
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):639-62. PubMed ID: 17009943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D; Desmazes-Dufeu N; Dusser D
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.
    Winstanley C; Fothergill JL
    FEMS Microbiol Lett; 2009 Jan; 290(1):1-9. PubMed ID: 19016870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.